U.S. COVID-19 Vaccine Product Information

On October 23, 2024, �ǿ��ֹ�� updated COVID-19 vaccine recommendations for people 65 years and older and for people who are moderately or severely immunocompromised. This page will be updated soon to align with the new recommendations. For more information, please visit the �ǿ��ֹ�� Newsroom.

COVID-19 Immunization Schedule

Find guidance for COVID-19 vaccination based on age, medical condition, and vaccination history.

Information by Brand

Pfizer-BioNTech

At-a-Glance
Standing Orders:
- 6 months–4 years of age
- 5 years of age and older

Moderna

At-a-Glance
Standing Orders:
- 6 months–4 years of age
- 5 years of age and older

Novavax

Storage Labels and BUD Guidance (all brands) – includes labels and beyond-use date guidance for flu, COVID-19, and RSV immunization products.

Education for Patients and Parents

Immunization providers should provide a Vaccine Information Statement (VIS) or Emergency Use Authorization (EUA) Factsheet for Recipients to a patient, parent, or legal representative before each dose of COVID-19 vaccine.

COVID-19 Vaccine Information Statement for people 12 years of age and older

Get the latest information for patients and parents on current COVID-19 vaccine recommendations.

Prevaccination Screening Checklist

�ǿ��ֹ�� is replacing the COVID-19 specific screening questionnaire these resources from Immunize.org that will help providers determine if a contraindication or precaution exists for all routinely recommended vaccines.

Emergency Use Instructions (EUI)

EUIs provide information about emergency use of FDA-approved medical products that may not be included in, or differ in some way, from the information provided in the FDA-approved labeling (package insert). New EUI for Pfizer-BioNTech and Moderna COVID-19 vaccines were issued August 23, 2024.

For Healthcare Providers

For Recipients and Caregivers

Additional Resources

�ǿ����ֹ���

U.S. COVID-19 Vaccine Product Information

�ǿ��ֹ��